Structure Therapeutics Inc.
GPCR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,427,624 | $1,497,237 | $951,288 | $951,288 |
| - Cash | $169,510 | $129,792 | $26,091 | $105 |
| + Debt | $3,862 | $5,453 | $260 | $621 |
| Enterprise Value | $1,261,976 | $1,372,898 | $925,457 | $951,804 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$157,236 | -$102,480 | -$52,284 | -$37,624 |
| % Margin | – | – | – | – |
| Net Income | -$122,526 | -$89,620 | -$51,321 | -$40,008 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.34 | -2.43 | -1.44 | -1.2 |
| % Growth | 3.7% | -68.8% | -20% | – |
| Operating Cash Flow | -$116,636 | -$79,488 | -$46,120 | -$32,160 |
| Capital Expenditures | -$1,290 | -$2,167 | -$155 | -$1,206 |
| Free Cash Flow | -$117,926 | -$81,655 | -$46,275 | -$33,366 |